CN103529202B - A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells - Google Patents
A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells Download PDFInfo
- Publication number
- CN103529202B CN103529202B CN201310419228.XA CN201310419228A CN103529202B CN 103529202 B CN103529202 B CN 103529202B CN 201310419228 A CN201310419228 A CN 201310419228A CN 103529202 B CN103529202 B CN 103529202B
- Authority
- CN
- China
- Prior art keywords
- cells
- cell
- wild
- sorting
- gate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004027 cell Anatomy 0.000 title claims abstract description 179
- 230000035772 mutation Effects 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 31
- 230000002269 spontaneous effect Effects 0.000 title claims abstract description 19
- 210000004408 hybridoma Anatomy 0.000 title claims abstract description 8
- 102100022002 CD59 glycoprotein Human genes 0.000 claims abstract description 29
- 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 claims abstract description 29
- 238000001514 detection method Methods 0.000 claims abstract description 15
- 101150114997 CD59 gene Proteins 0.000 claims abstract description 7
- 239000000725 suspension Substances 0.000 claims abstract description 5
- 239000000872 buffer Substances 0.000 claims description 15
- 238000010586 diagram Methods 0.000 claims description 15
- 238000000684 flow cytometry Methods 0.000 claims description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 238000001943 fluorescence-activated cell sorting Methods 0.000 claims description 7
- 101710149632 Pectinesterase A Proteins 0.000 claims description 6
- 238000012921 fluorescence analysis Methods 0.000 claims description 5
- 102000004142 Trypsin Human genes 0.000 claims description 4
- 108090000631 Trypsin Proteins 0.000 claims description 4
- 230000003698 anagen phase Effects 0.000 claims description 4
- 239000006285 cell suspension Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 239000012588 trypsin Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- 230000002950 deficient Effects 0.000 claims description 2
- 230000006862 enzymatic digestion Effects 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- 230000029087 digestion Effects 0.000 claims 1
- 238000002703 mutagenesis Methods 0.000 claims 1
- 231100000350 mutagenesis Toxicity 0.000 claims 1
- 238000004091 panning Methods 0.000 abstract description 6
- 206010064571 Gene mutation Diseases 0.000 abstract description 4
- 102000034287 fluorescent proteins Human genes 0.000 abstract description 2
- 108091006047 fluorescent proteins Proteins 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 15
- 108010055167 CD59 Antigens Proteins 0.000 description 4
- 102000001324 CD59 Antigens Human genes 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 241000699802 Cricetulus griseus Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 231100000025 genetic toxicology Toxicity 0.000 description 2
- 230000001738 genotoxic effect Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000003917 human chromosome Anatomy 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 238000002738 Giemsa staining Methods 0.000 description 1
- 101150046772 MIC1 gene Proteins 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710160107 Outer membrane protein A Proteins 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 239000002957 persistent organic pollutant Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229910052704 radon Inorganic materials 0.000 description 1
- SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 108010008595 sarcoma-associated antigen S1 Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/34—Purifying; Cleaning
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种降低野生型人鼠杂交瘤AL细胞自发突变背景的方法,包括野生型细胞收集;与荧光抗体的结合;制备上样悬液;细胞分选;保存。该方法操作简单,从收集细胞、与特异性荧光蛋白结合到分选,整个过程仅需4-5小时,并可同时获得能连续培养的未突变(CD59+)细胞和突变(CD59-)细胞,这在很大程度上提高CD59基因突变检测的效率。通过该方法,AL细胞的自发突变率可降至105存活细胞中约有30个突变细胞,较Panning后获得的自发突变下降2倍,有效提高了该突变检测系统的实验灵敏性。
The invention discloses a method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells, which comprises the steps of collecting wild-type cells; combining with fluorescent antibodies; preparing sample suspension; cell sorting; and preserving. The method is simple to operate, and the whole process from collecting cells, combining with specific fluorescent proteins to sorting, only takes 4-5 hours, and can simultaneously obtain unmutated (CD59 + ) cells and mutant (CD59 - ) cells that can be continuously cultured , which greatly improves the efficiency of CD59 gene mutation detection. Through this method, the spontaneous mutation rate of AL cells can be reduced to about 30 mutant cells in 10 5 surviving cells, which is 2 times lower than the spontaneous mutation obtained after Panning, which effectively improves the experimental sensitivity of the mutation detection system.
Description
技术领域 technical field
本发明涉及一种哺乳动物细胞突变检测技术领域,尤其涉及的是一种降低野生型人鼠杂交瘤AL细胞自发突变背景的方法。 The invention relates to the technical field of mammalian cell mutation detection, in particular to a method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells.
背景技术 Background technique
基因突变不仅是癌症发生的关键因素之一,而且是环境污染物遗传毒性评价的重要依据。AL细胞是中国仓鼠CHO细胞gly-A突变株与正常人成纤维细胞杂交后所得永生化细胞,含有一整套中国仓鼠CHO-K1染色体和一条人的11号染色体。人的11号染色体可编码多种细胞表面蛋白,其中包括CD59基因(旧称为MIC1基因)编码的CD59细胞表面抗原(旧称为S1抗原)。由于野生型AL细胞CD59基因正常表达时在细胞表面形成CD59抗原,在兔血清补体存在的情况下,该抗原与特异性抗体E7.1结合后,导致野生型细胞裂解而无法生存;而突变细胞因不能表达CD59蛋白,无法与抗体和补体作用而得以存活,在培养皿上形成肉眼可见的突变细胞克隆。根据这一特点,AL细胞已被广泛用于环境污染物如氡气、石棉、有机污染物、重金属等遗传毒性检测及相关机理研究。 Gene mutation is not only one of the key factors of cancer, but also an important basis for evaluating the genotoxicity of environmental pollutants. AL cells are immortalized cells obtained by crossing the gly - A mutant of Chinese hamster CHO cells with normal human fibroblasts, and contain a complete set of Chinese hamster CHO-K1 chromosomes and a human chromosome 11. Human chromosome 11 can encode a variety of cell surface proteins, including CD59 cell surface antigen (formerly known as S1 antigen) encoded by CD59 gene (formerly known as MIC1 gene). Due to the normal expression of the CD59 gene of wild-type A L cells, the CD59 antigen is formed on the cell surface. In the presence of rabbit serum complement, the antigen binds to the specific antibody E7.1, causing the wild-type cells to lyse and fail to survive; while the mutation The cells survived because they could not express CD59 protein and could not interact with antibodies and complements, and formed mutant cell clones visible to the naked eye on the culture dish. According to this feature, AL cells have been widely used in the detection of genotoxicity of environmental pollutants such as radon, asbestos, organic pollutants, heavy metals, and related mechanism research.
然而,在连续传代过程中,野生型AL细胞的自发突变细胞会不断增加,导致自发突变背景上升,基因突变检测的灵敏度下降,为了克服这一现象,在突变实验前,野生型AL细胞需采用Panning技术,除去CD59-的阴性细胞,以达到降低突变本底的目的。该过程具体如下: However, in the process of continuous passage, the spontaneous mutation cells of wild-type AL cells will continue to increase, resulting in an increase in the background of spontaneous mutations and a decrease in the sensitivity of gene mutation detection. In order to overcome this phenomenon, before the mutation experiment, wild-type AL cells Panning technology is required to remove CD59 - negative cells in order to reduce the mutation background. The process is as follows:
(1)山羊抗小鼠IgM处理普通平皿:10ml IgM/PBS(20μg/ml)IgM溶于PBS中)加入100mm普通平皿中,使其均匀的覆盖于皿底。室温,静止2小时。PBS清洗2次后,加入5ml1%FBS/PBS(1%小牛胎盘血清溶于PBS),黑暗中保存于4℃(可过夜); (1) Goat anti-mouse IgM treatment of ordinary plates: 10ml IgM/PBS (20μg/ml) IgM dissolved in PBS) added to 100mm ordinary plates, so that it evenly covers the bottom of the dish. Room temperature, let stand for 2 hours. After washing twice with PBS, add 5ml of 1% FBS/PBS (1% calf placenta serum dissolved in PBS), and store in the dark at 4°C (overnight);
(2)AL细胞收集:处于对数生长期的AL细胞酶解,悬浮于2%FBS/PBS(2%小牛胎盘血清溶于PBS)中。计数,离心,调整细胞密度至2×106/ml。细胞悬浮于含有0.2%CD59抗体的2%FBS/PBS中,冰浴30分钟。低温离心,预冷的2%FBS/PBS洗涤3次,并将细胞稀释至5×105/ml。 (2) AL cell collection: AL cells in logarithmic growth phase were hydrolyzed, suspended in 2% FBS/PBS (2% calf placental serum dissolved in PBS). Count, centrifuge, and adjust the cell density to 2×10 6 /ml. Cells were suspended in 2% FBS/PBS containing 0.2% CD59 antibody and kept on ice for 30 minutes. Centrifuge at low temperature, wash 3 times with pre-cooled 2% FBS/PBS, and dilute the cells to 5×10 5 /ml.
(3)细胞与山羊抗小鼠IgM相互作用:弃去平皿中1%FBS/PBS,将5ml悬浮于2%FBS/PBS中的细胞种植移入平皿。4℃孵育2小时。小心吸出上清夜,用预冷的2%FBS/PBS小心洗涤3次,除去没有贴壁的细胞和CD59-自发突变细胞。 (3) Interaction between cells and goat anti-mouse IgM: Discard 1% FBS/PBS in the plate, and plant 5ml of cells suspended in 2% FBS/PBS into the plate. Incubate at 4°C for 2 hours. Carefully aspirate the supernatant and wash carefully 3 times with pre-cooled 2% FBS/PBS to remove non-adherent cells and CD59 - spontaneous mutant cells.
(4)未突变细胞保存及检测:加入新鲜的F12完全培养液,连续培养3-4天,收集CD59+细胞,冻存于液氮。同时,需要对收集的细胞进行突变背景检测,这一过程需要14天。如果突变检测背景仍然偏高,需要重复上述步骤。一般情况下,细胞自发突变背景可降至每105 存活细胞中有70-80个突变细胞。由上可见,该方法操作过程繁琐,一个周期通常需要3周时间,特别是用IgM处理平皿和清洗突变细胞过程对实验操作人员技术的熟练程度有一定要求。同时,实验中所使用的特殊抗体—山羊抗小鼠IgM抗体价格较为昂贵,用量大。 (4) Preservation and detection of non-mutated cells: add fresh F12 complete culture medium, culture continuously for 3-4 days, collect CD59 + cells, and freeze them in liquid nitrogen. At the same time, the collected cells need to be tested for mutation background, which takes 14 days. If the mutation detection background is still high, the above steps need to be repeated. In general, the spontaneous mutation background of cells can be reduced to 70-80 mutant cells per 10 5 surviving cells. It can be seen from the above that the operation process of this method is cumbersome, and one cycle usually takes 3 weeks, especially the process of treating the plate with IgM and washing the mutant cells requires a certain degree of proficiency of the experimental operator. At the same time, the special antibody used in the experiment—goat anti-mouse IgM antibody is relatively expensive and used in large quantities.
发明内容 Contents of the invention
本发明的目的在于克服现有技术的不足,提供了一种降低野生型人鼠杂交瘤AL细胞自发突变背景的方法,基于流式细胞分选技术结合特异性荧光抗体,筛选突变及未突变细胞。 The purpose of the present invention is to overcome the deficiencies of the prior art and provide a method for reducing the background of spontaneous mutations in wild-type human-mouse hybridoma AL cells, based on flow cytometry technology combined with specific fluorescent antibodies to screen for mutations and non-mutations cell.
本发明是通过以下技术方案实现的,本发明包括以下步骤: The present invention is achieved through the following technical solutions, and the present invention comprises the following steps:
(1)野生型细胞收集 (1) Collection of wild-type cells
收取培养至对数生长期的AL细胞,酶解消化,悬浮于F12完全培养基中,清洗后制成浓度为±106细胞/100μl的单细胞悬液; Collect the AL cells cultured to the logarithmic growth phase, enzymatically digest, suspend in F12 complete medium, wash and make a single cell suspension with a concentration of ±10 6 cells/100 μl;
(2)与荧光抗体的结合 (2) Binding to fluorescent antibodies
加100μl预冷的流式细胞缓冲液重悬细胞后,按配比浓度加入荧光标记的CD59特异性抗体,4℃避光反应30~60分钟后,用预冷的FACS Buffer清洗离心,去除未结合的抗体; Add 100 μl of pre-cooled flow cytometry buffer to resuspend the cells, add fluorescently labeled CD59-specific antibody according to the proportioned concentration, and react in the dark at 4°C for 30-60 minutes, then wash and centrifuge with pre-cooled FACS Buffer to remove unbound cells. Antibodies;
(3)制备上样悬液 (3) Preparation of sample suspension
重悬细胞于预冷的流式细胞缓冲液后,送入流式细胞分选仪待测; After resuspending the cells in the pre-cooled flow cytometry buffer, send them to the flow cytometry sorter for testing;
(4)细胞分选 (4) Cell sorting
使用流式细胞分选仪进行分选; sorting using a flow cytometer;
(5)保存 (5) save
将分选获得的未突变细胞扩增,液氮保存。 The unmutated cells obtained by sorting were expanded and stored in liquid nitrogen.
所述细胞包括AL细胞、由该细胞发展的各种缺陷型细胞以及构建的细胞系。 The cells include AL cells, various defective cells developed from the cells, and constructed cell lines.
所述步骤(1)中,酶解消化所用的为胰蛋白酶,为质量含量为0.25%胰蛋白酶和0.02%EDTA溶于PBS缓冲液制得。 In the step (1), trypsin is used for enzymatic digestion, which is prepared by dissolving 0.25% trypsin and 0.02% EDTA in PBS buffer.
所述步骤(4)包括以下步骤: The step (4) includes the following steps:
a、建立前向散射FSC/侧向散射SSC散点图,通过初步设定门P1,排除死细胞和细胞碎片,找到目标细胞群; a. Establish a forward scatter FSC/side scatter SSC scatter diagram, and preliminarily set the gate P1 to exclude dead cells and cell debris, and find the target cell population;
b、建立SSC-W/FSC-W散点图,通过二次设定门P2,排除双联体细胞; b. Establish SSC-W/FSC-W scatter diagram, and exclude doublet cells by setting gate P2 twice;
c、建立PE-A/FSC-A荧光分析点图,根据对照细胞群位置设定阴阳性界定门,界定门以下为阴性CD59-细胞群,界定门以上为阳性CD59+细胞群。 c. Establish the PE-A/FSC-A fluorescence analysis point diagram, set the positive and negative gates according to the position of the control cell population, define negative CD59 - cell populations below the gate, and positive CD59 + cell populations above the gate.
所述分选获得的细胞用于连续培养,或者作为CD59基因流式检测突变技术中的阳性CD59+和阴性CD59-对照细胞 The cells obtained by the sorting are used for continuous culture, or as positive CD59 + and negative CD59 - control cells in CD59 gene flow cytometry detection mutation technology
本发明使用的AL细胞来源由THEODORE T.PUCK等在Genetics of Somatic Mammalian Cells: Lethal Antigens as Genetic Markers for Study of Human Linkage Groups中披露,Proc.Nat.Acad.Sci.USA Vol.68,No.12,pp.3102-3106,December1971。哺乳动物体细胞的遗传学:致命抗原作为遗传标记来研究人类连锁基因群。期刊Proc.Nat.Acad.Sci.全称为《美国国家科学院院刊》,简称PNAS。这篇文章发表于1971年11月PNAS杂志上第12期68卷,页码3102-3106。 The AL cell source used in the present invention is disclosed in Genetics of Somatic Mammalian Cells: Lethal Antigens as Genetic Markers for Study of Human Linkage Groups by THEODORE T.PUCK etc., Proc.Nat.Acad.Sci.USA Vol.68, No. 12, pp. 3102-3106, December 1971. Genetics of mammalian somatic cells: lethal antigens as genetic markers to study human linked gene groups. The full name of the journal Proc.Nat.Acad.Sci. is "Proceedings of the National Academy of Sciences of the United States", or PNAS for short. This article was published in the November 1971 issue of PNAS Magazine, Volume 12, Volume 68, Pages 3102-3106.
本发明相比现有技术具有以下优点: Compared with the prior art, the present invention has the following advantages:
1、本发明突变背景更低:一般通过传统的Panning技术本底突变值可降低至每105存活细胞中有70-80个突变(CD59-)细胞,而通过本方法,可进一步降低突变背景,达到每105存活细胞中约有30个突变细胞; 1. The mutation background of the present invention is lower: Generally, the background mutation value can be reduced to 70-80 mutant (CD59 - ) cells per 10 5 surviving cells through traditional Panning technology, and through this method, the mutation background can be further reduced , reaching about 30 mutant cells per 10 5 surviving cells;
2、效率高:一般传统方法步骤繁琐,细胞经过多步处理后丢失较多,上百万细胞经过抗体筛选得率仅为几万个细胞。而采用流式分选技术,检测量每秒最高可达1×104个细胞,分选数目每秒最高可达500个细胞,一小时内就可分选出上百万个CD59+细胞; 2. High efficiency: Generally, the steps of traditional methods are cumbersome, and many cells are lost after multi-step treatment, and the yield of millions of cells after antibody screening is only tens of thousands of cells. With flow sorting technology, the detection amount can reach up to 1×10 4 cells per second, and the sorting number can reach up to 500 cells per second, and millions of CD59 + cells can be sorted within one hour;
3、周期短:传统Panning技术整个过程比较繁琐,一个周期通常需要3周时间,特别是用IgM处理平皿和清洗突变细胞过程对实验操作人员技术的熟练程度有一定要求,本方法从收集细胞、与特异性荧光蛋白结合、分选,整个过程仅需4-5小时,简单快速且不易受实验环境条件的干扰,并可同时获得能连续培养的未突变(CD59+)细胞和突变(CD59-)细胞,这在很大程度上提高CD59基因突变检测的效率; 3. Short cycle: The whole process of traditional Panning technology is cumbersome, and a cycle usually takes 3 weeks, especially the process of treating the plate with IgM and cleaning the mutant cells has certain requirements for the proficiency of the experimental operator. This method starts from collecting cells, Combined with specific fluorescent protein and sorted, the whole process only takes 4-5 hours, simple, fast and not easily disturbed by experimental environmental conditions, and can simultaneously obtain non-mutated (CD59 + ) cells and mutant (CD59 - ) cells, which greatly improves the efficiency of CD59 gene mutation detection;
4、实验费用低:传统Panning技术中使用的山羊抗小鼠IgM抗体价格昂贵,抗体用量大,而本方法中使用的荧光抗体相对较为便宜,且每次实验用量非常少,在极大程度上节省了实验费用。 4. Low experimental cost: The goat anti-mouse IgM antibody used in the traditional Panning technique is expensive, and the amount of antibody used is large, while the fluorescent antibody used in this method is relatively cheap, and the amount of each experiment is very small, to a great extent Save experiment cost.
附图说明 Description of drawings
图1是FSC/SSC散点图; Figure 1 is the FSC/SSC scatter diagram;
图2是SSC-W/FSC-W散点图; Figure 2 is a scatter diagram of SSC-W/FSC-W;
图3是PE-A/FSC-A阴性细胞群荧光分析点图; Fig. 3 is the fluorescence analysis point diagram of PE-A/FSC-A negative cell group;
图4是PE-A/FSC-A阳性细胞群荧光分析点图; Fig. 4 is the fluorescence analysis point diagram of PE-A/FSC-A positive cell group;
图5是流式分选未突变AL细胞参数设置图; Fig. 5 is a flow cytometric sorting diagram of parameter settings for unmutated AL cells;
图6是克隆法检测流式分选前后AL细胞自发突变背景对比图; Figure 6 is a background comparison of AL cell spontaneous mutation before and after flow cytometry detection by cloning method;
图7是不同来源AL细胞自发突变率对比结果。 Figure 7 is a comparison of the spontaneous mutation rates of AL cells from different sources.
具体实施方式 Detailed ways
下面对本发明的实施例作详细说明,本实施例在以本发明技术方案为前提下进行实施,给出了详细的实施方式和具体的操作过程,但本发明的保护范围不限于下述的实施例。 The embodiments of the present invention are described in detail below. This embodiment is implemented on the premise of the technical solution of the present invention, and detailed implementation methods and specific operating procedures are provided, but the protection scope of the present invention is not limited to the following implementation example.
本实施例包括以下步骤: This embodiment includes the following steps:
(1)野生型细胞收集 (1) Collection of wild-type cells
收取培养至对数生长期的AL细胞,酶解消化,悬浮于F12完全培养基中,清洗后制成浓度为±106细胞/100μl的单细胞悬液; Collect the AL cells cultured to the logarithmic growth phase, enzymatically digest, suspend in F12 complete medium, wash and make a single cell suspension with a concentration of ±10 6 cells/100 μl;
(2)与荧光抗体的结合 (2) Binding to fluorescent antibodies
加100μl预冷的流式细胞缓冲液FACS Buffer重悬细胞后,按配比浓度加入荧光标记的CD59特异性抗体,4℃避光反应30~60分钟后,用预冷的FACS Buffer清洗离心,去除未结合的抗体;荧光抗体浓度:通常一个实验样本为±106细胞/100μl悬液,每100μl细胞悬液加10-20μl荧光抗体; Add 100 μl pre-cooled flow cytometry buffer FACS Buffer to resuspend the cells, add fluorescently labeled CD59-specific antibody according to the proportioned concentration, react in the dark at 4°C for 30-60 minutes, wash and centrifuge with pre-cooled FACS Buffer, remove Unbound antibody; fluorescent antibody concentration: usually an experimental sample is ±10 6 cells/100μl suspension, add 10-20μl fluorescent antibody per 100μl cell suspension;
(3)制备上样悬液 (3) Preparation of sample suspension
重悬细胞于预冷的FACS Buffer后,FACS Buffer是流式细胞缓冲液,配方为:质量比为1%的牛血清白蛋白,10mM叠氮钠溶解于磷酸盐缓冲液PBS(含有钙和镁离子,pH=7.0),送入流式细胞分选仪待测; After resuspending cells in pre-cooled FACS Buffer, FACS Buffer is a flow cytometry buffer, the formula is: bovine serum albumin with a mass ratio of 1%, 10mM sodium azide dissolved in phosphate buffered saline PBS (containing calcium and magnesium ions, pH=7.0), sent to the flow cytometer for testing;
(4)细胞分选 (4) Cell sorting
使用流式细胞分选仪进行分选;细胞分选采用的仪器为BD FACS AriaTMⅢCell Sorter; Sorting was performed using a flow cytometer; the instrument used for cell sorting was BD FACS Aria TM III Cell Sorter;
a、如图1所示,在流式细胞仪上获取数据时,建立前向散射FSC/侧向散射SSC散点图,SSC用来检测细胞内部颗粒度,FSC用来检测细胞的大小。通过初步设定门P1,排除死细胞和细胞碎片,找到目标细胞群,并调节各个光电倍增管装置以确定所有要分析的细胞群都在点图的可视范围内。具体如下:通过设置和调节FSC阈值,将大部分的细胞碎片、气泡和激光背景噪的干扰排除在分析区域之外(都应该设在FSC-low/SSC-low区域),接下来在FSC/SSC点图中圈出目标细胞群的周围区域(P1),这个区域可以被称为“P1-FSC/SSC”,P1设门主要是根据细胞最集中的部分圈定其范围,排除周围过大过小的分散的细胞颗粒或碎片杂质; a. As shown in Figure 1, when acquiring data on the flow cytometer, establish a forward scatter FSC/side scatter SSC scatter diagram, SSC is used to detect the particle size inside the cell, and FSC is used to detect the size of the cell. By initially setting the gate P1, excluding dead cells and cell debris, finding the target cell population, and adjusting each photomultiplier device to ensure that all the cell populations to be analyzed are within the visible range of the dot plot. The details are as follows: By setting and adjusting the FSC threshold, most of the cell debris, air bubbles and laser background noise are excluded from the analysis area (all should be set in the FSC-low/SSC-low area), and then in the FSC/ The surrounding area (P1) of the target cell group is circled in the SSC dot diagram. This area can be called "P1-FSC/SSC". Small dispersed cell particles or debris impurities;
b、建立SSC-W/FSC-W散点图,通过二次设定门P2,排除双联体细胞,保证最后进行荧光检测和分选的细胞是单个细胞,如图2所示,W指收集信号的宽度。SSC-W/FSC-W全称为侧向散射角-宽度/前向散射角-宽度散点图。宽度(如SSC-W)常用来区分双联体细胞。由于双联体细胞所得到的信号会比单个细胞大,反应在SSC-W/FSC-W图上即为纵坐标和横坐标值较大较离散的点状区域,因此根据细胞的大小和颗粒度的宽度二次设门P2来排除双联体; b. Establish the SSC-W/FSC-W scatter diagram, and exclude the doublet cells by setting the gate P2 twice to ensure that the final fluorescent detection and sorting cells are single cells, as shown in Figure 2, W means The width of the collected signal. SSC-W/FSC-W stands for Side Scatter Angle-Width/Forward Scatter Angle-Width Scatter Plot. Width (such as SSC-W) is often used to distinguish doublet cells. Since the signal obtained by the doublet cell will be larger than that of a single cell, the reaction on the SSC-W/FSC-W diagram is a point-like area with large vertical and horizontal coordinates, so according to the size of the cell and the size of the particle The width of the degree is set gate P2 twice to exclude doublets;
c、建立PE-A/FSC-A荧光分析点图,如图3和图4所示,根据对照细胞群位置设定阴阳性界定门,界定门以下为阴性CD59-细胞群,界定门以上为阳性CD59+细胞群,图3中界定门以下Q4区为阴性(CD59-)细胞群,图4中界定门以上Q2区为阳性(CD59+)细胞群,这两群细胞中必然包含一些假阳性/假阴性的细胞或杂质,可通过精确调节界定门以上或以下的 分选区域,以及调节分选模式来获得高纯度的阳性和阴性对照细胞,PE为抗体偶联的染料-藻红蛋白;A为荧光脉冲的面积,面积积分比荧光脉冲的高度H更能准确反应检测指标的含量。PE-A/FSC-A全称为荧光染料-荧光脉冲面积/细胞大小-荧光脉冲面积分析点图。 c. Establish the PE-A/FSC-A fluorescence analysis point map, as shown in Figure 3 and Figure 4, set the negative and positive limit gates according to the position of the control cell population, the negative CD59 - cell population is defined below the gate, and the negative CD59- cell population is defined above the gate. Positive CD59 + cell population, the Q4 area below the gate is defined as negative (CD59 - ) cell population in Figure 3, and the Q2 area above the gate is defined as positive (CD59 + ) cell population in Figure 4, these two populations of cells must contain some false positives /False-negative cells or impurities can be obtained by precisely adjusting the sorting area defined above or below the gate, and adjusting the sorting mode to obtain high-purity positive and negative control cells. PE is an antibody-coupled dye-phycoerythrin; A is the area of the fluorescence pulse, and the area integral can more accurately reflect the content of the detection index than the height H of the fluorescence pulse. The full name of PE-A/FSC-A is fluorescent dye-fluorescence pulse area/cell size-fluorescence pulse area analysis dot plot.
阴阳性界定门是根据阳性和阴性对照细胞群分别占收集细胞的百分比划分的,通过设置和调节PE对应的FL2荧光通道的电压值和四象限门位置,使检测到的阳性和阴性细胞纯度都分别达到99.9%及以上,这时对应的象限门位置就是划分阴阳性对照细胞的界定门。 The positive and negative control gates are divided according to the percentages of the positive and negative control cell populations in the collected cells. By setting and adjusting the voltage value of the FL2 fluorescence channel corresponding to PE and the position of the four-quadrant gate, the purity of the detected positive and negative cells is equal. Reaching 99.9% and above respectively, at this time the corresponding quadrant gate position is the defining gate for dividing negative and positive control cells.
图5表示通过分选获得低突变背景的CD59+细胞,图中根据对照细胞设定的界定门(虚线所示)以上Q2部分为CD59+的阳性细胞群,界定门以下Q4部分为CD59-的阴性细胞群。Q2部分均可作为分选区域,通过调节界定门位置和设门区域(箭头和方框所示)进一步提高分选纯度。图中P3部分即为最终分选的细胞群。 Figure 5 shows the CD59 + cells with low mutation background obtained by sorting. In the figure, the Q2 part above the defined gate (shown by the dotted line) set by the control cells is the CD59 + positive cell population, and the Q4 part below the defined gate is the CD59- positive cell population. Negative cell population. The Q2 part can be used as a sorting area, and the sorting purity can be further improved by adjusting the position of the defined gate and the area of the gate (shown by the arrow and the box). Part P3 in the figure is the final sorted cell population.
(5)保存 (5) save
将分选获得的未突变细胞扩增,液氮保存。 The unmutated cells obtained by sorting were expanded and stored in liquid nitrogen.
如图6所示,对于本实施例分选后的AL细胞,通过克隆法检测流式分选前后AL细胞自发突变背景,左边为分选前的AL细胞,右边为分选后的AL细胞,从由图中可以看出,流式分选可显著降低本底突变数目。 As shown in Figure 6, for the AL cells after sorting in this embodiment, the spontaneous mutation background of AL cells before and after flow cytometry sorting was detected by cloning method, the left side is the AL cells before sorting, and the right side is the sorted AL cells AL cells, as can be seen from the figure, flow sorting can significantly reduce the number of background mutations.
克隆法检测原理为:野生型AL细胞CD59基因正常表达时在细胞表面形成CD59抗原,在兔血清补体存在的情况下,该抗原与特异性抗体E7.1结合后,导致野生型细胞裂解而无法生存;而突变细胞因不能表达CD59蛋白,无法与抗体和补体作用而得以存活,在培养皿上形成肉眼可见的突变细胞克隆。 The detection principle of the cloning method is: when the CD59 gene of wild-type A L cells is normally expressed, the CD59 antigen is formed on the cell surface, and in the presence of rabbit serum complement, the antigen binds to the specific antibody E7.1, resulting in the lysis of the wild-type cells Can not survive; mutant cells cannot survive because they cannot express CD59 protein and cannot interact with antibodies and complements, forming mutant cell clones visible to the naked eye on the culture dish.
具体过程: Specific process:
1、将处理后细胞重新连续培养7-14天,使处理后的存活细胞有足够的时间从生长暂时停滞状态中恢复,同时,也使突变细胞繁殖的后代细胞表面不再残留CD59抗原: 1. Re-cultivate the treated cells continuously for 7-14 days, so that the surviving cells after treatment have enough time to recover from the temporary stagnation of growth, and at the same time, the CD59 antigen will no longer remain on the surface of the progeny of the mutant cells:
2、加抗体补体与CD59抗原相互作用并连续培养7至10天,直至形成肉眼可见克隆,弃去培养液,固定,Giemsa染色,计算存活细胞的克隆数; 2. Add antibody complement to interact with CD59 antigen and continue to culture for 7 to 10 days until visible clones are formed, discard the culture medium, fix, Giemsa staining, and calculate the number of clones of surviving cells;
3、统计突变细胞克隆数,计算细胞突变率。细胞突变率=突变细胞的克隆数/校准后每1×105存活的细胞数。 3. Count the number of mutant cell clones and calculate the cell mutation rate. Cell mutation rate = clone number of mutant cells/number of surviving cells per 1×10 5 after calibration.
图7是对不同来源AL细胞自发突变率进行对比的结果。野生型AL细胞为124/105cells;通过Panning技术,AL细胞自发突变率可降至80/105cells,而流式分选技术更进一步降低突变背景,达30/105cells。 Figure 7 is the result of comparing the spontaneous mutation rate of AL cells from different sources. The wild-type AL cells are 124/10 5 cells; through Panning technology, the spontaneous mutation rate of AL cells can be reduced to 80/10 5 cells, and the flow sorting technology further reduces the mutation background to 30/10 5 cells.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310419228.XA CN103529202B (en) | 2013-09-13 | 2013-09-13 | A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310419228.XA CN103529202B (en) | 2013-09-13 | 2013-09-13 | A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103529202A CN103529202A (en) | 2014-01-22 |
| CN103529202B true CN103529202B (en) | 2015-04-15 |
Family
ID=49931380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310419228.XA Active CN103529202B (en) | 2013-09-13 | 2013-09-13 | A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103529202B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108486212B (en) * | 2018-04-28 | 2022-03-04 | 中国科学院合肥物质科学研究院 | A method for antagonizing the biological toxicity of heavy metal arsenic |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102783416A (en) * | 2012-07-25 | 2012-11-21 | 陕西天正达生物科技股份有限公司 | Breeding method for resistant super-male polyploidy asparagus based on flow cytometry |
| CN103215352A (en) * | 2013-03-29 | 2013-07-24 | 中国医学科学院血液病医院(血液学研究所) | Assay kit for detecting stimulated emission depletion 2 (STED 2) gene mutation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7754155B2 (en) * | 2002-03-15 | 2010-07-13 | Ross Amelia A | Devices and methods for isolating target cells |
| BRPI0607486B8 (en) * | 2005-03-03 | 2021-05-25 | Immunomedics Inc | 1243 humanized antibody against hla-dr present in hladr+ cells, pharmaceutical composition, kit and use of said antibodies. |
-
2013
- 2013-09-13 CN CN201310419228.XA patent/CN103529202B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102783416A (en) * | 2012-07-25 | 2012-11-21 | 陕西天正达生物科技股份有限公司 | Breeding method for resistant super-male polyploidy asparagus based on flow cytometry |
| CN103215352A (en) * | 2013-03-29 | 2013-07-24 | 中国医学科学院血液病医院(血液学研究所) | Assay kit for detecting stimulated emission depletion 2 (STED 2) gene mutation |
Non-Patent Citations (2)
| Title |
|---|
| 梁喆等.人-鼠及人-(人-鼠)杂交瘤中染色体行为与杂交瘤稳定性的关系.《第四军医大学学报》.1993,第14卷(第1期),53-57. * |
| 青石棉诱导AL细胞CD59基因突变和DNA氧化损伤的研究;许安等;《中华劳动卫生职业病杂志》;20040229;第22卷(第1期);43-46 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103529202A (en) | 2014-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Guilliams et al. | Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches | |
| Olsen et al. | The anatomy of single cell mass cytometry data | |
| Partlová et al. | Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma | |
| Yang et al. | Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells | |
| Braasch et al. | The changing dielectric properties of CHO cells can be used to determine early apoptotic events in a bioprocess | |
| CN105067808A (en) | High-purity circulation tumor cell enriching method and kit | |
| Amoli et al. | EBV Immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood | |
| CN106834271A (en) | A kind of high-throughput screening method of deletion mutant | |
| Hamot et al. | Method validation for automated isolation of viable peripheral blood mononuclear cells | |
| EP2972359A1 (en) | Enrichment of circulating tumor cells by depleting white blood cells | |
| Gallagher et al. | Selection of high-producing clones using FACS for CHO cell line development | |
| Li et al. | Detection of carcinoma in serous effusions: a review | |
| González-González et al. | Elimination of contaminants from cell preparations using aqueous two-phase partitioning | |
| CN103529202B (en) | A method for reducing the spontaneous mutation background of wild-type human-mouse hybridoma AL cells | |
| CN112945667B (en) | Preparation method of blood single-cell suspension for removing nucleated red blood cells | |
| Carroll et al. | ACSD labelling and magnetic cell separation: a rapid method of separating antibody secreting cells from non-secreting cells | |
| Assenmacher et al. | Detection and isolation of cytokine secreting cells using the cytometric cytokine secretion assay | |
| Dong et al. | DC-derived CXCL10 promotes CTL activation to suppress ovarian cancer | |
| Kumpel et al. | Phenotype and mRNA expression of syncytiotrophoblast microparticles isolated from human placenta | |
| Yano et al. | DNA extraction for short tandem repeat typing from mixed samples using anti-human leukocyte CD45 and ABO blood group antibodies | |
| Gole et al. | Modified cIg-FISH protocol for multiple myeloma in routine cytogenetic laboratory practice | |
| CN116879142A (en) | Method for counting CD34-positive cells in hematopoietic stem cells | |
| CN117844759A (en) | Method for stimulating CAR-T cells by protein magnetic bead coupling simulated tumor cells | |
| LudueñA et al. | Expression of liver and placental alkaline phosphatases in Chang liver cells | |
| Wing et al. | An improved method for the detection of cell surface antigens in samples of low viability using flow cytometry |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |